期刊文献+

凝血和纤溶与缺血性心脏病的关系 被引量:7

Correlation between Ischemic Heart Disease and Coagulation and Fibrinolysis
下载PDF
导出
摘要 纤维蛋白原为重要的凝血因子,越来越多的研究表明高纤维蛋白原水平导致高凝状态,诱发血管疾病造成缺血性损伤。纤溶酶原激活物抑制物1是血浆纤溶活性的主要决定因素。异常升高纤溶酶原激活物抑制物1阻碍纤维蛋白分解,从而增加血浆纤维蛋白原。高纤维蛋白原水平导致高凝状态促进血栓形成。纤溶酶原激活物抑制物参与多种代谢性疾病血栓前状态的形成,造成动脉血栓形成的危险性增加。纤溶酶原激活物抑制物1、纤维蛋白原不仅在冠心病的发病机制中发挥着重要作用,而且与冠心病患者的不良预后有关。 Fibrinogen are important clotting factors,more and more research shows that high fibrinogen level leads to high condensation state,induces vascular disease causing ischemic damage.The plasminogen activator inhibitor-1(PAI-1)is the main factor determining the plasma fibrinolytic activity.The elevated PAI-l impedes the decomposition of fibrin,and then results in the increased plasma fibrinogen.The high level of fibrinogen leads to the hypercoagulabale state and accelerates the thrombosis.PAI-1 is involved in the prethrombotic state formation of a variety of metabolic diseases,resulting in increased risk of arterial thrombosis.PAI-1 and fibrinogen not only play an important role in the pathogenensis of coronary heart disease,but is also related to the poor prognosis of the disease.
作者 张霖 张戈
出处 《医学综述》 2012年第11期1639-1641,共3页 Medical Recapitulate
关键词 缺血性心脏病 纤维蛋白原 纤溶酶原激活物抑制物1 Ischemic heart disease Fibrinogen Plasminogen activator inhibitor-1
  • 相关文献

参考文献2

二级参考文献30

  • 1中华医学会糖尿病学分会代谢综合征研究协作组.中华医学会糖尿病学分会关于代谢综合征的建议[J].中国糖尿病杂志,2004,12(3):156-161. 被引量:3053
  • 2刘梅颜,胡大一,闫丽,刘文红,刘如辉.高水平纤维蛋白原与冠状动脉狭窄严重程度相关性探讨[J].中华内科杂志,2004,43(11):820-823. 被引量:37
  • 3赵佩琪,徐济民,盛净,杨菊贤,黄震华,王健.灯盏细辛对犬急性心肌缺血时AT-Ⅲ活性、tPA和PAI的影响[J].上海第二医科大学学报,1996,16(1):26-28. 被引量:9
  • 4詹三华,宋玉丽,季燕,马秀英,张孟改.灯盏细辛对急性脑梗死患者血浆内皮素及肿瘤坏死因子的影响及意义[J].广东医学,2006,27(1):120-121. 被引量:13
  • 5Yiming L, Wei H, Aihua L, et al. Neuroprotective effects of breviscapine against apoptosis induced by transient focal cerebral ischaemia in rats[ J]. J Pharm Pharmacol,2008, 60(3 ) :349-355.
  • 6Bank I, Libourel EJ, Middeldorp S ,et al. Elevated levels of FVIII:C within families are associated with an increased risk for venous and arterial thrombosis[ J]. J Thromb Haemost, 2005,3 ( 1 ) : 79-84.
  • 7Heberlein KR, Straub AC, Best AK, et al. Plasminogen activator inhibitor-1 regulates myoendothelial junction formation[J]. Circ Res,2010,106(6) :1092-1102.
  • 8Izuhara Y, Yamaoka N, Kodama H, et al. A novel inhibitor of plasminogen activator inhibitor-1 provides antithrombotic benefits devoid of bleeding effect in nonhuman primates [J]. J Cereb Blood Flow Metab,2010,30( 5) :904-912.
  • 9Douglas E Vaughan. Angiotensin,fibrinolysis,and vascular homeostasis[ J]. Am J Cardiol, 2001,87 (suppl) : 18C- 24C.
  • 10Pan ZW, Zhang Y, Mei DH,et al. Scutellarin exerts its anti-hypertrophic effects via suppressing the Ca^2+ -mediated calcineurin and CaMKII signaling pathways [ J ]. Naunyn Schmiedebergs Arch Pharmacol, 2010,381 ( 2 ) : 137-145.

共引文献7

同被引文献63

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部